Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8811
|
pubmed:dateCreated |
1992-7-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
340
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
117-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1351986-Antiphospholipid Syndrome,
pubmed-meshheading:1351986-Female,
pubmed-meshheading:1351986-Humans,
pubmed-meshheading:1351986-Male,
pubmed-meshheading:1351986-Myocardial Infarction,
pubmed-meshheading:1351986-Norway,
pubmed-meshheading:1351986-Risk Factors,
pubmed-meshheading:1351986-Thromboembolism
|
pubmed:year |
1992
|
pubmed:articleTitle |
Antiphospholipid antibodies and recurrent thrombo-occlusive events.
|
pubmed:publicationType |
Letter,
Comment
|